Stock MRSN MERSANA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Mersana Therapeutics, Inc.

Equities

MRSN

US59045L1061

Market Closed - Nasdaq
Other stock markets
 21:00:00 13/05/2024 BST 		5-day change 1st Jan Change
2.62 USD -3.32% Intraday chart for Mersana Therapeutics, Inc. -25.14% +12.93%
05-09 Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09 Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mersana Therapeutics Names Martin Huber as Chief Executive
MT
Mersana Therapeutics Announces Management Changes
CI
Mersana Therapeutics, Inc. Announces Chief Executive Officer Changes
CI
Mersana Therapeutics Chief People Officer Carla Poulson Named One of Savoy Magazine’s 2022 Most Influential Black Executives in Corporate America
AQ
Insider Buy: Mersana Therapeutics
MT
Nuvalent Appoints Mersana Therapeutics Chief Executive Anna Protopapas as Board Chair
MT
Insider Buy: Mersana Therapeutics
MT
Insider Buy: Mersana Therapeutics
MT
Mersana Therapeutics Named to 2021 List of Top Places to Work in Massachusetts by The Boston Globe
AQ
Mersana Therapeutics : Names Brian DeSchuytner Chief Financial Officer
MT
Mersana Therapeutics, Inc. Appoints Mohan Bala as SVP, Strategic Product Planning & Program Leadership
CI
Mersana Therapeutics, Inc. Announces Executive Changes
CI
Mersana Therapeutics Announces Appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer
CI
Mersana Therapeutics, Inc. Appoints Allene Diaz to Serve as A Class II Director
CI
Mersana Therapeutics, Inc. Appoints Carla Poulson as Chief Human Resources Officer
CI
Mersana Therapeutics Appoints Arvin Yang, M.D., Ph.D. as Senior Vice President and Chief Medical Officer
CI
Mersana Therapeutics, Inc. Appoints Chuck Miller as Senior Vice President of Regulatory Affairs
CI
Mersana Therapeutics, Inc. Announces Board Changes
CI
Mersana Therapeutics, Inc. Announce Executive Changes Effective from September 30, 2019
CI
Mersana Therapeutics, Inc. Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRSN Stock
  4. News Mersana Therapeutics, Inc.
  5. Insiders